Annual Retained Earnings
-$153.02 M
-$51.98 M-51.45%
December 1, 2023
Summary
- As of February 22, 2025, BCAX annual retained earnings is -$153.02 million, with the most recent change of -$51.98 million (-51.45%) on December 1, 2023.
- During the last 3 years, BCAX annual retained earnings has fallen by -$51.98 million (-51.45%).
- BCAX annual retained earnings is now -51.45% below its all-time high of -$101.04 million, reached on December 1, 2022.
Performance
BCAX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$200.06 M
-$17.48 M-9.57%
September 30, 2024
Summary
- As of February 22, 2025, BCAX quarterly retained earnings is -$200.06 million, with the most recent change of -$17.48 million (-9.57%) on September 30, 2024.
- BCAX quarterly retained earnings is now -30.74% below its all-time high of -$153.02 million, reached on December 1, 2023.
Performance
BCAX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BCAX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.5% | - |
| 3 y3 years | -51.5% | - |
| 5 y5 years | -51.5% | - |
BCAX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.5% | at low | -30.7% | at low |
| 5 y | 5-year | -51.5% | at low | -30.7% | at low |
| alltime | all time | -51.5% | at low | -30.7% | at low |
Bicara Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$200.06 M(+9.6%) |
| Jun 2024 | - | -$182.58 M(+19.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$153.02 M(+51.5%) | -$153.02 M |
| Dec 2022 | -$101.04 M | - |
FAQ
- What is Bicara Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Bicara Therapeutics?
- What is Bicara Therapeutics annual retained earnings year-on-year change?
- What is Bicara Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Bicara Therapeutics?
What is Bicara Therapeutics annual retained earnings?
The current annual retained earnings of BCAX is -$153.02 M
What is the all time high annual retained earnings for Bicara Therapeutics?
Bicara Therapeutics all-time high annual retained earnings is -$101.04 M
What is Bicara Therapeutics annual retained earnings year-on-year change?
Over the past year, BCAX annual retained earnings has changed by -$51.98 M (-51.45%)
What is Bicara Therapeutics quarterly retained earnings?
The current quarterly retained earnings of BCAX is -$200.06 M
What is the all time high quarterly retained earnings for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly retained earnings is -$153.02 M